Wednesday 24 October 2012

Elan on track as multiple sclerosis drug sales rise

DUBLIN (Reuters) - Irish drugmaker Elan Corp Plc said third-quarter revenue rose by 10 percent as sales of its multiple sclerosis (MS) drug grew.

via Reuters: Health News Read More Here..

No comments:

Post a Comment